Cheryl Maguire
Analyst · Goldman Sachs. Please proceed
Thanks Mark, and good morning. Our fourth quarter adjusted EBITDA of $105 million is a record performance for us in the fourth quarter. Additionally, we generated adjusted EPS of $0.90 in the quarter. Turning to page 5, you'll see a summary of our key balance sheet and cash flow metrics. Our continued profitability enabled us to maintain a strong liquidity position. At the end of 2022, we had approximately $458 million of total liquidity, including approximately $394 million in cash and short-term investments. This is after we repurchased approximately 13.2 million shares of our stock at an average price of approximately $13 per share, exhausting the $175 million share repurchase program that we began in May of 2022. As of the 13.2 million shares, we bought back nine million shares from our largest stockholder, who completed secondary offerings of a portion of their position in our stock in August and November of 2022. Through these transactions, we were able to reduce our shares outstanding by approximately 15%, while at the same time increasing the trading liquidity of our stock. During 2022, we generated cash flow from operations of $346 million and had capital expenditures of $46 million, translating into $300 million of free cash flow. For the year, we returned approximately 60% of our free cash flow to investors through our share repurchase program. Additionally, we ended the year with a net debt to trailing 12-month EBITDA leverage ratio of less than one time, well below our target leverage ratio in a mid-cycle or normalized pricing environment of below 2.5 times. Page 6 bridges our fourth quarter adjusted EBITDA of $105 million to adjusted EBITDA for the fourth quarter 2021 of $90 million. The positive selling price impact is shown net of increased variable costs versus the fourth quarter of 2021. Sales volumes were lower in the fourth quarter as a result of planned turnaround activity at our prior facility, which concluded in mid-October and the loss of approximately one week of production in the fourth quarter at our Cherokee and El Dorado facilities, due to the impact of freezing cold weather in late December. Page 7 illustrates the strong bottom line improvement we've delivered over the past several years. This is the result of favorable pricing trends, operational improvements, new customer contracts and investments we've made to optimize our product distribution and mix. While we anticipate 2023 EBITDA will be lower than 2022, as a result of nitrogen pricing moderating off of peak levels we still expect to generate substantial profit and cash flow, further positioning us to implement our growth strategy, which Mark will discuss later in the call. Looking at the first quarter, the Nola UAN benchmark pricing is currently at approximately $265 a tonne. Additionally, the Tampa ammonia benchmark price settled at $790 per metric ton in February versus $1,135 per metric ton last February. The year-over-year change largely reflects lower natural gas prices in Europe, which have come down from very high levels in 2022 and industrial demand softening in Europe and Asia. With that said, US natural gas prices have also declined and currently stand at a fraction of the cost in Europe, keeping intact the competitive advantage that US nitrogen producers enjoy. Relative to our natural gas feedstock cost, while US gas costs have since moderated, we do have approximately 75% of our first quarter gas needs locked in at approximately $6.30 per MMBtu for Q1. With respect to sales volumes, as previously announced, our Cherokee facility resumed production with a Phase 3 start on January 14, 2023. The despite lower production at that site in January and the delayed movement of fertilizer resulting in volumes moving to the second quarter, we expect overall higher sales volumes of ammonia and UAN as compared to the first quarter of 2022, assuming reasonable weather conditions. Additionally, nitric acid and AN volumes are expected to be in line with the healthy first quarter of 2022. So given our view on sales volumes and pricing, locked-in natural gas costs and the approximately $10 million impact from the Cherokee freeze event that impacted production through mid-January, we would expect the first quarter adjusted EBITDA to be in the range of $55 million to $65 million. Please keep in mind, our expected EBITDA range for the quarter is based on our current view of pricing. Looking forward to the balance of the year, we provide considerations for our full year 2023 on Slides 8 and 9. On Slide 8, you can see our expected ammonia production and sales volumes for the full year of 2023. As a result of expected improvement in operating rates, due in part to our turnarounds at El Dorado and Pryor in 2022 and the absence of any turnarounds in 2023, we expect meaningful year-over-year improvement in ammonia production as well as all of our downstream products. We expect to invest approximately $60 million to $80 million of CapEx in our facilities during 2023. This includes approximately $50 million to $60 million of investments related to plant reliability and safety with the balance earmarked for margin enhancement projects aimed at improving the efficiency of our operations, expanding our commercial footprint and investing in storage and loading capabilities at our facilities. Slide 9 covers a range of variable and fixed plant expenses as well as SG&A for 2023. Our expectations for fixed costs reflect investments we've made in key talent to support our growth as well as inflation in wages and other costs. Note, that we expect our effective tax rate for the year to be approximately 25%. However, we do not expect to be a material cash taxpayer in 2023 as we continue to utilize our NOLs. And now I'll turn it back over to Mark.